Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boomerang Corporation is a digital health and diagnostics company focused on at-home testing and related wellness services. The business emerged from Lotus Bio-Technology Development Corp. and described a model in which users receive self-collection test kits, ship samples back to partner or company labs, and obtain digital results with personalized wellness recommendations. Public disclosures and company communications indicate an emphasis on consumer-accessible testing in men's health, women's health, sexual health, and COVID-19. The company appears to have operated as a small OTC-traded healthcare issuer under the ticker LBTD, with a medical laboratories classification and a commercial-stage service offering rather than a traditional therapeutic drug pipeline. Available evidence does not show a conventional biotech therapeutics pipeline, drug targets, or clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boomerang Corporation.